After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Ovid Therapeutics Inc is $21.40M. A total of 0.73 million shares were traded on the day, compared to an average of 398.55K shares.
In the most recent transaction, ALEXANDER MARGARET A. sold 5,279 shares of OVID for 0.56 per share on Feb 26 ’25. After the transaction, the President and COO now owns 73,406 company shares. In a previous transaction on Feb 26 ’25, Rona Jeffrey A sold 3,902 shares at 0.56 per share. OVID shares that CBFO owns now total 67,973.
Among the insiders who bought shares, ALEXANDER MARGARET A. acquired of 6,810 shares on Jan 27 ’25 at a per-share price of $0.73. This resulted in the President and COO holding 34,935 shares of OVID after the transaction.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, OVID has a high of $3.31 and a low of $0.24.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. OVID’s latest balance sheet shows that the firm has $187.80M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $14.80M in liabilities at the time. Its Book Value Per Share was $0.83, while its Total Shareholder’s Equity was $179.75M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OVID is Buy with a score of 5.00.
